APA (7th ed.) Citation

J, S., K, D., A, W., M, B., F, E., E, F., . . . N, T. (2019). Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. Frontiers in pharmacology, 10, 400. https://doi.org/10.3389/fphar.2019.00400

Chicago Style (17th ed.) Citation

J, Sachs, et al. "Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5." Frontiers in Pharmacology 10 (2019): 400. https://doi.org/10.3389/fphar.2019.00400.

MLA (9th ed.) Citation

J, Sachs, et al. "Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5." Frontiers in Pharmacology, vol. 10, 2019, p. 400, https://doi.org/10.3389/fphar.2019.00400.